structure of 1092977-61-1

2-[(3-Butoxyphenethyl)Amino]-N,N-Dimethylacetamide(CAS 1092977-61-1)

CAS No.: 1092977-61-1 Brand: MolBest
M. Ft.: C16H26N2O2 Cat. No: G7601517
M. Wt.: 278.39 MDL: MFCD28502433
Storage: 2-8°C Use: For laboratory research use only
Purity Grade Package Stock Price Quantity
95%
Documents:COASDS
RG 100MG In Stock 219 USD
95%
Documents:COASDS
RG 250MG In Stock 280 USD
95%
Documents:COASDS
RG 1G In Stock 757 USD
95%
Documents:COASDS
RG 5G In Stock 3634 USD
Your region is eligible for ordering.
Should you have any questions, please contact us by Email.
Batch COA
Available
NMR Spectrum
Verified
In Stock
Fast Shipping
ISO 9001
Quality System

Promotion

Physical and chemical properties of 1092977-61-1

Acidity coefficient

7.99±0.19(Predicted)

Boiling Point

412.1±30.0 °C at 760 mmHg

Density

1.0±0.1 g/cm3

Exact Mass

278.199432

Flash Point

203.0±24.6 °C

Index of Refraction

1.510

LogP

2.38

Molecular Formula

C16H26N2O2

Molecular Weight

278.390

Vapour Pressure

0.0±1.0 mmHg at 25°C

Download COA of 1092977-61-1

CAS/Product ID
*Required fields
Lot/Batch Number
*Required fields

Download SDS of 1092977-61-1

Pictograms

Signal Word

Warning

Hazard Statements

H302 Harmful if swallowed
H315 Causes skin irritation
H319 Causes serious eye irritation
H335 May cause respiratory irritation

Safety Data Sheet

Q&A for CAS 1092977-61-1

1. How can I verify product quality?
Every batch is tested in accordance with ISO 9001 requirements. We provide a Certificate of Analysis (COA), NMR spectrum, purity report, and test methods with each shipment. Third-party retesting is supported, and we offer a full refund if our data is incorrect.

2. What is the delivery time?
Orders are shipped on the second business day via FedEx, DHL, or UPS. International deliveries typically arrive within 7 business days (subject to customs clearance).

3. What if the received product doesn’t meet quality standards?
If the product does not match the COA or has a quality issue, we will issue a full refund or replacement upon verification.

4. Are hazardous labels included? How is safe shipping ensured?
Hazardous products are labeled and packaged in compliance with international regulations and shipped with an up-to-date Safety Data Sheet (SDS) to ensure safe and compliant transport.

5. Do you offer technical support?
Yes. Our technical team is available to assist with questions about product use, storage, purity requirements, applications, and more.

6. Are volume discounts available?
Yes. We offer competitive pricing for bulk orders. Please submit a quotation request, and we’ll provide a customized offer.

7. Do you provide samples?
Yes, samples are available for select products for testing and validation. Please submit a sample request or contact our sales team to confirm availability and specifications.

8. Do you have products in stock?
Items marked “In Stock” on our website are ready for immediate shipment, usually within 1–2 business days. Large packs or custom specifications require lead time confirmation.

9. Can you customize purity or packaging?
Yes. We support customization of purity, packaging size, and special testing requirements. Please share your detailed needs, and we’ll provide a solution.

10. Is the COA consistent with the shipped batch?
Yes. The COA provided with your shipment matches the actual batch and includes the batch number. COAs shown online are for reference or from previous batches.

11. Do you support long-term supply agreements?
Yes. We offer stable batch consistency, pricing agreements, and safety stock options for long-term customers to ensure uninterrupted supply.

12. What payment methods do you accept?
We accept bank transfer (T/T), PayPal, and other methods. Credit terms may be available for qualified long-term partners.

Applications of 1092977-61-1

Evenamide is primarily being investigated for its therapeutic potential in:

  • Schizophrenia: Particularly in treatment-resistant cases where traditional antipsychotics have failed.
  • Other psychiatric disorders: Due to its unique mechanism of action targeting glutamatergic neurotransmission.

The ongoing clinical trials aim to establish its efficacy as an add-on therapy to existing antipsychotic treatments.

Operate under the ISO 9001 system